论文部分内容阅读
Hybrid polymeric micelles based on N-octyl-N-trimethyl Chitosan/S-100 coated with CMCNa for tumor-ta
【机 构】
：
State Key Laboratory of Natural Medicines,Department of Pharmaceutics,China Pharmaceutical Universit
【出 处】
：
2012年中国药物制剂大会——中国药学会药剂专业委员会年会、亚洲阿登制药技术研讨会暨国际控释协会中国分会年会
【发表日期】
：
2012年10期
其他文献
Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes modified with tra
会议
Paclitaxel-loaded poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate)nanoparticles for loadi
Preparation of Surface modification polylactide drug-loaded nanoparticles for intranasal delivery an
BACKGROUND The human olfactory system is linked to a channel in the brain and the surrounding environment.After nasal administration,the drug can reach the brain through the following two ways.(1) blo
会议
A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene thera
The study aimed to develop a biomimetic nanovector,reconstituted high density lipoprotein (rHDL),mediating targeted cholesterol-conjugated siRNA (Chol-siRNA) delivery for Pokemon gene silencing therap
Aim:To synthesis a novel chitosan derivative,N-octyl-N-arginine chitosan(OACS),with a mimetic structure of Arginine rich Peptides.OACS micelles loaded Insulin (Ins-OACS) was prepared,characterized and
Aim:Lactoferrin (Lf),a mammalian cationic iron-binding glycoprotein belonging to the transferrin(Tf) family,has been widely used in a number of areas from infant diarrhea and support for newborn growt
Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-paclitaxel conjuga
Aims:A novel ligend-PEG-drug conjugate,octreotide-polyethene glycol-paclitaxel (OCT-PEG-PTX) was developed for efficient cancer therapy.Method:The ligand OCT was first conjugated to the carboxyl group
Atherosclerotic lesions-targeted delivery of tashinone ⅡA by biomemetic recombinant high density lip
OBJECTIVE:The purpose of our study was to comprehensively compare in vivo performances of discoidal and spherical recombinant high density lipoproteins loaded with cardiovascular drug tanshinone IIA (